Global Nifedipine Market Growth 2025-2031
Description
The global Nifedipine market size is predicted to grow from US$ 1228 million in 2025 to US$ 1970 million in 2031; it is expected to grow at a CAGR of 8.2% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
The nifedipine market based on geography can be further segmented into North America, Europe, Asia Pacific, South America, and Rest of the World. North America will account for the largest share in 2022. The growth of this segment is due to factors such as widespread obesity among the American public leading to increased ailments such as heart disease, angina, hypertension, etc. In 2021, the United States leads every other country on earth in obesity rates. Approximately 36.20% of adults in the United States face overweight issues, which leads the calcium channel blocker drugs market.
However, Asia Pacific is expected to be the fastest growing segment. This growth is due to the increasing elderly population, especially in countries like India and China, the rise in chronic diseases, and the continuous improvement of medical infrastructure as governments allocate countless funds for development.
LP Information, Inc. (LPI) ' newest research report, the “Nifedipine Industry Forecast” looks at past sales and reviews total world Nifedipine sales in 2024, providing a comprehensive analysis by region and market sector of projected Nifedipine sales for 2025 through 2031. With Nifedipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nifedipine industry.
This Insight Report provides a comprehensive analysis of the global Nifedipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nifedipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nifedipine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nifedipine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nifedipine.
This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Segmentation by Application:
Hypertension
Heart Disease
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Actavis
Teva
Pfizer
Shyndec
Honglin Pharmaceutical
Huanghai
Yabao
Lifeon Pharmaceutical
EASEHEAL Pharmaceutical
ApicHope
Simcere
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nifedipine market?
What factors are driving Nifedipine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nifedipine market opportunities vary by end market size?
How does Nifedipine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
The nifedipine market based on geography can be further segmented into North America, Europe, Asia Pacific, South America, and Rest of the World. North America will account for the largest share in 2022. The growth of this segment is due to factors such as widespread obesity among the American public leading to increased ailments such as heart disease, angina, hypertension, etc. In 2021, the United States leads every other country on earth in obesity rates. Approximately 36.20% of adults in the United States face overweight issues, which leads the calcium channel blocker drugs market.
However, Asia Pacific is expected to be the fastest growing segment. This growth is due to the increasing elderly population, especially in countries like India and China, the rise in chronic diseases, and the continuous improvement of medical infrastructure as governments allocate countless funds for development.
LP Information, Inc. (LPI) ' newest research report, the “Nifedipine Industry Forecast” looks at past sales and reviews total world Nifedipine sales in 2024, providing a comprehensive analysis by region and market sector of projected Nifedipine sales for 2025 through 2031. With Nifedipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nifedipine industry.
This Insight Report provides a comprehensive analysis of the global Nifedipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nifedipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nifedipine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nifedipine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nifedipine.
This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Segmentation by Application:
Hypertension
Heart Disease
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Actavis
Teva
Pfizer
Shyndec
Honglin Pharmaceutical
Huanghai
Yabao
Lifeon Pharmaceutical
EASEHEAL Pharmaceutical
ApicHope
Simcere
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nifedipine market?
What factors are driving Nifedipine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nifedipine market opportunities vary by end market size?
How does Nifedipine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
113 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Nifedipine by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Nifedipine by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
